Latest & greatest articles for folic acid

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on folic acid or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on folic acid and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for folic acid

41. Practice Parameter update: Managment issues for women with epilepsy - Focus on pregnancy: Vitamin K, folic acid, blood levels, and breastfeeding

Practice Parameter update: Managment issues for women with epilepsy - Focus on pregnancy: Vitamin K, folic acid, blood levels, and breastfeeding DOI 10.1212/WNL.0b013e3181a6b325 2009;73;142-149 Published Online before print April 27, 2009 Neurology C. L. Harden, P. B. Pennell, B. S. Koppel, et al. of Neurology and American Epilepsy Society Technology Assessment Subcommittee of the American Academy the Quality Standards Subcommittee and Therapeutics and Vitamin K, folic acid, blood levels (...) , MD J. Hopp, MD T.Y. Ting, MD W.A. Hauser, MD D.Thurman,MD,MPH P.W.Kaplan,MB,FRCP J.N. Robinson, MD J.A. French, MD S. Wiebe, MD A.N. Wilner, MD B. Vazquez, MD L. Holmes, MD A. Krumholz, MD R. Finnell, PhD P.O. Shafer, RN, MN C. Le Guen ABSTRACT Objective:To reassess the evidence for management issues related to the care of women with epilepsy (WWE) during pregnancy, including preconceptional folic acid use, prenatal vitamin K use, risk of hemorrhagic disease of the newborn, clinical implications

2009 American Epilepsy Society

42. Management issues for women with epilepsy-focus on pregnancy: vitamin k, folic acid, blood levels, and breastfeeding

Management issues for women with epilepsy-focus on pregnancy: vitamin k, folic acid, blood levels, and breastfeeding Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding | Neurology Advertisement Search for this keyword Main menu User menu Search Search for this keyword The most widely read and highly cited peer-reviewed neurology journal Share July 14, 2009 ; 73 (2) Special (...) Article Practice Parameter update: Management issues for women with epilepsy—Focus on pregnancy (an evidence-based review): Vitamin K, folic acid, blood levels, and breastfeeding Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society C. L. Harden , P. B. Pennell , B. S. Koppel , C. A. Hovinga , B. Gidal , K. J. Meador , J. Hopp , T. Y. Ting , W. A. Hauser , D. Thurman , P. W. Kaplan , J. N

2009 American Academy of Neurology

43. Cancer incidence and mortality after treatment with folic acid and vitamin B12. Full Text available with Trip Pro

Cancer incidence and mortality after treatment with folic acid and vitamin B12. Recently, concern has been raised about the safety of folic acid, particularly in relation to cancer risk.To evaluate effects of treatment with B vitamins on cancer outcomes and all-cause mortality in 2 randomized controlled trials.Combined analysis and extended follow-up of participants from 2 randomized, double-blind, placebo-controlled clinical trials (Norwegian Vitamin Trial and Western Norway B Vitamin (...) Intervention Trial). A total of 6837 patients with ischemic heart disease were treated with B vitamins or placebo between 1998 and 2005, and were followed up through December 31, 2007.Oral treatment with folic acid (0.8 mg/d) plus vitamin B(12) (0.4 mg/d) and vitamin B(6) (40 mg/d) (n = 1708); folic acid (0.8 mg/d) plus vitamin B(12) (0.4 mg/d) (n = 1703); vitamin B(6) alone (40 mg/d) (n = 1705); or placebo (n = 1721).Cancer incidence, cancer mortality, and all-cause mortality.During study treatment

2009 JAMA

44. High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials

High-dose folic acid supplementation effects on endothelial function and blood pressure in hypertensive patients: a meta-analysis of randomized controlled clinical trials Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2009 DARE.

45. Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Asse Full Text available with Trip Pro

Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Asse Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics (...) and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society Practice parameter update: management issues for women with epilepsy - focus on pregnancy (an evidence-based review): vitamin K, folic acid, blood levels, and breastfeeding. Report of the Quality Standards Subcommittee and Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology and American Epilepsy Society Harden CL, Pennell PB, Koppel BS, Hovinga CA, Gidal B, Meador KJ

2009 DARE.

46. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force

Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force Wolff T, Witkop CT, Miller T, Syed SB Record Status This is a bibliographic (...) record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Wolff T, Witkop CT, Miller T, Syed SB. Folic acid supplementation for the prevention of neural tube defects: an update of the evidence for the U.S. Preventive Services Task Force. Rockville: Agency for Healthcare Research and Quality (AHRQ). Evidence Synthesis No 70. 2009 Authors' objectives To update the evidence on folic acid

2009 Health Technology Assessment (HTA) Database.

47. Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. (Abstract)

Folic acid with or without vitamin B12 for the prevention and treatment of healthy elderly and demented people. Folate deficiency can result in congenital neural tube defects and megaloblastic anaemia. Low folate levels may be due to insufficient dietary intake or inefficient absorption, but impaired metabolic utilization also occurs.Because B12 deficiency can produce a similar anaemia to folate deficiency, there is a risk that folate supplementation can delay the diagnosis of B12 deficiency (...) , which can cause irreversible neurological damage. Folic acid supplements may sometimes therefore include vitamin B12 supplements with simultaneous administration of vitamin B12.Lesser degrees of folate inadequacy are associated with high blood levels of the amino acid homocysteine which has been linked with the risk of arterial disease, dementia and Alzheimer's disease. There is therefore interest in whether dietary supplementation can improve cognitive function in the elderly.However, any apparent

2008 Cochrane

48. Daily folic acid supplementation for 3 years reduced age related hearing loss

Daily folic acid supplementation for 3 years reduced age related hearing loss Daily folic acid supplementation for 3 years reduced age related hearing loss | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers of institutional accounts (...) Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily folic acid supplementation for 3 years reduced age related hearing loss Article Text Treatment Daily folic acid supplementation for 3 years reduced age related hearing loss Statistics from Altmetric.com Request Permissions If you

2008 Evidence-Based Nursing

49. Daily folic acid supplementation for 3 years improved cognitive function in older persons Full Text available with Trip Pro

Daily folic acid supplementation for 3 years improved cognitive function in older persons Daily folic acid supplementation for 3 years improved cognitive function in older persons | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts OR managers (...) of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily folic acid supplementation for 3 years improved cognitive function in older persons Article Text Therapeutics Daily folic acid supplementation for 3 years improved cognitive function in older persons Statistics

2008 Evidence-Based Medicine

50. Aspirin and folic acid for the prevention of recurrent colorectal adenomas (Abstract)

Aspirin and folic acid for the prevention of recurrent colorectal adenomas Although observational studies have found regular aspirin use to be associated with a reduced risk of colorectal neoplasia, results from randomized trials using aspirin have been inconsistent. Dietary folate intake also has been found to be associated with a reduced risk of colorectal neoplasms in observational studies.A multicenter, randomized, double-blind trial of aspirin (300 mg/day) and folate supplements (0.5 mg

2008 EvidenceUpdates Controlled trial quality: predicted high

51. Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people

Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Daily oral vitamin B-12 with or without folic acid for 24 weeks did not improve cognitive function in elderly people Article Text Therapeutics Daily oral

2008 Evidence-Based Medicine

52. Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. Full Text available with Trip Pro

Effect of folic acid and B vitamins on risk of cardiovascular events and total mortality among women at high risk for cardiovascular disease: a randomized trial. Recent randomized trials among patients with preexisting cardiovascular disease (CVD) have failed to support benefits of B-vitamin supplementation on cardiovascular risk. Observational data suggest benefits may be greater among women, yet women have been underrepresented in published randomized trials.To test whether a combination (...) of folic acid, vitamin B6, and vitamin B12 lowers risk of CVD among high-risk women with and without CVD.Within an ongoing randomized trial of antioxidant vitamins, 5442 women who were US health professionals aged 42 years or older, with either a history of CVD or 3 or more coronary risk factors, were enrolled in a randomized, double-blind, placebo-controlled trial to receive a combination pill containing folic acid, vitamin B6, and vitamin B12 or a matching placebo, and were treated for 7.3 years from

2008 JAMA Controlled trial quality: predicted high

53. A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy

A systematic review of interventions to increase awareness, knowledge, and folic acid consumption before and during pregnancy Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2008 DARE.

54. Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. Full Text available with Trip Pro

Effect of combined folic acid, vitamin B6, and vitamin B12 on cancer risk in women: a randomized trial. Folate, vitamin B(6), and vitamin B(12) are thought to play an important role in cancer prevention.To evaluate the effect of combined folic acid, vitamin B(6), and vitamin B(12) treatment on cancer risk in women at high risk for cardiovascular disease.In the Women's Antioxidant and Folic Acid Cardiovascular Study, 5442 US female health professionals aged 42 years or older, with preexisting (...) cardiovascular disease or 3 or more coronary risk factors, were randomly assigned to receive either a daily combination of folic acid, vitamin B(6), and vitamin B(12) or a matching placebo. They were treated for 7.3 years from April 1998 through July 31, 2005.Daily supplementation of a combination of 2.5 mg of folic acid, 50 mg of vitamin B(6), and 1 mg of vitamin B(12) (n = 2721) or placebo (n = 2721).Confirmed newly diagnosed total invasive cancer or breast cancer.A total of 379 women developed invasive

2008 JAMA Controlled trial quality: predicted high

55. Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction

Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Lowering homocysteine with folic acid and B vitamins did not prevent vascular events after myocardial infarction Article Text Therapeutics Lowering homocysteine

2007 Evidence-Based Medicine

56. Lowering homocysteine with folic acid and B vitamins did not prevent vascular events in vascular disease Full Text available with Trip Pro

Lowering homocysteine with folic acid and B vitamins did not prevent vascular events in vascular disease Lowering homocysteine with folic acid and B vitamins did not prevent vascular events in vascular disease | BMJ Evidence-Based Medicine We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password (...) For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Lowering homocysteine with folic acid and B vitamins did not prevent vascular events in vascular disease Article Text Therapeutics Lowering homocysteine with folic acid and B

2007 Evidence-Based Medicine

57. Reduction in neural-tube defects after folic acid fortification in Canada. Full Text available with Trip Pro

Reduction in neural-tube defects after folic acid fortification in Canada. In 1998, folic acid fortification of a large variety of cereal products became mandatory in Canada, a country where the prevalence of neural-tube defects was historically higher in the eastern provinces than in the western provinces. We assessed changes in the prevalence of neural-tube defects in Canada before and after food fortification with folic acid was implemented.The study population included live births (...) bifida (a decrease of 53%) than for anencephaly and encephalocele (decreases of 38% and 31%, respectively).Food fortification with folic acid was associated with a significant reduction in the rate of neural-tube defects in Canada. The decrease was greatest in areas in which the baseline rate was high.Copyright 2007 Massachusetts Medical Society.

2007 NEJM

58. Folic acid supplements and risk of facial clefts: national population based case-control study. Full Text available with Trip Pro

Folic acid supplements and risk of facial clefts: national population based case-control study. To explore the role of folic acid supplements, dietary folates, and multivitamins in the prevention of facial clefts.National population based case-control study.Infants born 1996-2001 in Norway.377 infants with cleft lip with or without cleft palate; 196 infants with cleft palate alone; 763 controls.Association of facial clefts with maternal intake of folic acid supplements, multivitamins (...) risk of cleft lip was among women with folate rich diets who also took folic acid supplements and multivitamins (0.36, 0.17 to 0.77). Folic acid provided no protection against cleft palate alone (1.07, 0.56 to 2.03).Folic acid supplements during early pregnancy seem to reduce the risk of isolated cleft lip (with or without cleft palate) by about a third. Other vitamins and dietary factors may provide additional benefit.

2007 BMJ

59. Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Full Text available with Trip Pro

Effect of 3-year folic acid supplementation on cognitive function in older adults in the FACIT trial: a randomised, double blind, controlled trial. Low folate and raised homocysteine concentrations in blood are associated with poor cognitive performance in the general population. As part of the FACIT trial to assess the effect of folic acid on markers of atherosclerosis in men and women aged 50-70 years with raised plasma total homocysteine and normal serum vitamin B12 at screening, we report (...) here the findings for the secondary endpoint: the effect of folic acid supplementation on cognitive performance.Our randomised, double blind, placebo controlled study took place between November, 1999, and December, 2004, in the Netherlands. We randomly assigned 818 participants 800 mug daily oral folic acid or placebo for 3 years. The effect on cognitive performance was measured as the difference between the two groups in the 3-year change in performance for memory, sensorimotor speed, complex

2007 Lancet Controlled trial quality: predicted high

60. Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Full Text available with Trip Pro

Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. Laboratory and epidemiological data suggest that folic acid may have an antineoplastic effect in the large intestine.To assess the safety and efficacy of folic acid supplementation for preventing colorectal adenomas.A double-blind, placebo-controlled, 2-factor, phase 3, randomized clinical trial conducted at 9 clinical centers between July 6, 1994, and October 1, 2004. Participants included 1021 men and women (...) with a recent history of colorectal adenomas and no previous invasive large intestine carcinoma.Participants were randomly assigned in a 1:1 ratio to receive 1 mg/d of folic acid (n = 516) or placebo (n = 505), and were separately randomized to receive aspirin (81 or 325 mg/d) or placebo. Follow-up consisted of 2 colonoscopic surveillance cycles (the first interval was at 3 years and the second at 3 or 5 years later).The primary outcome measure was occurrence of at least 1 colorectal adenoma. Secondary

2007 JAMA Controlled trial quality: predicted high